Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11639393 Anti-CCR8 antibodies

Overview Structured Data Issues Contributors Activity

All edits

Edits on 14 Aug, 2023

"Add patent inventor"

Golden AI

edited on 14 Aug, 2023

Edits made to:

Infobox (+4 properties)

Infobox

Patent Inventor Names

Amanda M. Schmidt Paustian0

Andrew J. McCluskey0

Jane Seagal0

Julie L. Wilsbacher0

Edits on 3 May, 2023

"Created via: Entity Importer"

Golden AI

created this topic on 3 May, 2023

Edits made to:

Infobox (+15 properties)

Article (+114 characters)

‌

US Patent 11639393 Anti-CCR8 antibodies

Article

The present disclosure provides anti-CCR8 antibodies, including compositions and methods of using such antibodies.

Infobox

Is a

Patent

Patent Applicant

AbbVie Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116393930

Date of Patent

May 2, 2023

Patent Application Number

178155050

Date Filed

July 27, 2022

Patent Citations

‌

US Patent 10087259 Depleting tumor-specific tregs

‌

US Patent 10550191 Method of treating cancer with an anti-CCR8 having antibody-dependent cell-mediated cytotoxicity (ADCC) activity against cells expressing CCR8

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11639393 Anti-CCR8 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API